Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Short Interest Down 53.1% in July

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the recipient of a significant drop in short interest in July. As of July 31st, there was short interest totaling 4,819 shares, a drop of 53.1% from the July 15th total of 10,281 shares. Based on an average trading volume of 105,236 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.9% of the company’s stock are short sold.

Defiance Daily Target 2X Long LMND ETF Stock Down 1.9%

Shares of LMNX traded down $0.17 during trading hours on Friday, hitting $8.88. The company had a trading volume of 17,570 shares, compared to its average volume of 48,024. The firm has a fifty day moving average price of $13.80 and a 200-day moving average price of $17.18. The company has a debt-to-equity ratio of 0.52, a quick ratio of 6.08 and a current ratio of 8.37. The stock has a market capitalization of $4.88 million, a price-to-earnings ratio of 17.41 and a beta of -18.70. Defiance Daily Target 2X Long LMND ETF has a 52-week low of $6.90 and a 52-week high of $55.00.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.